From:  Predictive markers of response to immune checkpoint inhibitor rechallenge in metastatic non-small cell lung cancer

Multivariate analysis for PFS and OS based on the NEO score

NEO score groupPFSOS
HR (95% CI)PHR (95% CI)P
Favorable1 [Reference]1 [Reference]
Poor7.30 (2.62–20.84)< 0.00115.34 (4.16–36.90)< 0.001
Return to article view

HR: hazard ratio; PFS: progression-free survival; OS: overall survival